Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (14690)	2/11/1998 10:36:00 PM
From: Proton	Respond to of 32384

Re: Resisting the Rats While I think we will see a price pop tomorrow, I don't expect anything too large. Heavens, I don't necessarily think we'll see all those resistances hit tomorrow. :-O Pý

To: Andrew H who wrote (14690)	2/11/1998 10:43:00 PM
From: tonyt	Respond to of 32384

> first there was leptin Have they finished dotting the 'i''s and crossing the 't''s yet? :-)

To: Andrew H who wrote (14690)	2/11/1998 11:45:00 PM
From: Machaon	Read Replies (1) \| Respond to of 32384

<< While I think we will see a price pop tomorrow, I don't expect anything too large. >> Andy, I hope you are right. I'd like to pick up some more LGND under $14 per share. With probable CNBC and "etc" hype tomorrow, I wonder what kind of a pop we'll see? I'd be surprised if we didn't see $15 at least once during the day. Isn't the FDA is supposed to go onto a fast-track for drugs that show overwhelming beneficial possibilities, especially in life or death situations? If true, it would be nice if LGND, and cancer patients, benefited from the new doctrine. Regards, and good luck, Bob and...... GO LGND!!!